# THE TRAVEL II TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve Via Jugular Vein

Study · id `cardio:ct-nct05194423` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05194423](<https://clinicaltrials.gov/study/NCT05194423>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05194423

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.

## Technical summary

Registry record NCT05194423. Allocation not applicable; no masking; primary purpose treatment. Start 2022-03-01 (anticipated); primary completion 2027-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT05194423, source copy `cardio:ctgov-nct05194423-2022-01-18`, retrieved 2026-10-26)
- Planned start: 2022-03-01 (anticipated) (ClinicalTrials.gov record NCT05194423, source copy `cardio:ctgov-nct05194423-2022-01-18`, retrieved 2026-10-26)
- Primary completion: 2027-03 (anticipated) (ClinicalTrials.gov record NCT05194423, source copy `cardio:ctgov-nct05194423-2022-01-18`, retrieved 2026-10-26)
- Completion: 2027-03 (anticipated) (ClinicalTrials.gov record NCT05194423, source copy `cardio:ctgov-nct05194423-2022-01-18`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05194423, source copy `cardio:ctgov-nct05194423-2022-01-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05194423-2022-01-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: THE TRAVEL II TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve Via Jugular Vein
- Condition: Tricuspid Valve Regurgitation
- Intervention (Device): Tricuspid Valve Replacement System via jugular vein
- Lead sponsor: Changhai Hospital
- Lead sponsor class: OTHER
- Collaborator: Shanghai Zhongshan Hospital
- Collaborator class: OTHER
- Collaborator: Fu Wai Hospital, Beijing, China
- Collaborator class: OTHER
- Collaborator: Beijing Anzhen Hospital
- Collaborator class: OTHER
- Collaborator: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Collaborator class: OTHER
- Collaborator: West China Hospital
- Collaborator class: OTHER
- Collaborator: Xijing Hospital
- Collaborator class: OTHER
- Collaborator: Guangdong Provincial People's Hospital
- Collaborator class: OTHER
- Collaborator: Second Affiliated Hospital, Zhejiang University, School of Medicine
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Tricuspid regurgitation (`cardio:tricuspid-regurgitation`)
- Registry lists this organization as the lead sponsor: Changhai Hospital (`cardio:org-changhai-hospital`)
- Registry lists this organization as a collaborator: Shanghai Zhongshan Hospital (`cardio:org-shanghai-zhongshan-hospital`)
- Registry lists this organization as a collaborator: Fu Wai Hospital, Beijing, China (`cardio:org-fu-wai-hospital-beijing-china`)
- Registry lists this organization as a collaborator: Beijing Anzhen Hospital (`cardio:org-beijing-anzhen-hospital`)
- Registry lists this organization as a collaborator: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (`cardio:org-union-hospital-tongji-medical-college-huazhong-university-090806`)
- Registry lists this organization as a collaborator: West China Hospital (`cardio:org-west-china-hospital`)
- Registry lists this organization as a collaborator: Xijing Hospital (`cardio:org-xijing-hospital`)
- Registry lists this organization as a collaborator: Guangdong Provincial People's Hospital (`cardio:org-guangdong-provincial-people-s-hospital`)
- Registry lists this organization as a collaborator: Second Affiliated Hospital, Zhejiang University, School of Medicine (`cardio:org-second-affiliated-hospital-zhejiang-university-school-of-bfd3ac`)

## Provenance

Content hash: 09c7a65f929976c905c4155bb1bf5fe5dfc5eb533e1023aeed24437ea5e16b65
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
